Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018291740> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2018291740 endingPage "185" @default.
- W2018291740 startingPage "185" @default.
- W2018291740 abstract "Editor,—Hyperimmunoglobulin E syndrome (HIES) is a rare primary immunodeficiency defined by recurrent infections and markedly elevated serum immunoglobulin E (IgE) concentration. Because the primary defect in HIES is unknown, there is no specific treatment. In few cases, continuous treatment with trimethoprim sulfamethoxazole, recombinant interferon gamma or cyclosporin A have been used to reduce the serum IgE levels (up to 20%, 55%, and 95%, respectively).1 2 However, adverse effects with such long term treatments have been described in children with HIES.2 We report the …" @default.
- W2018291740 created "2016-06-24" @default.
- W2018291740 creator A5003412641 @default.
- W2018291740 creator A5004863632 @default.
- W2018291740 creator A5089928210 @default.
- W2018291740 date "2000-08-01" @default.
- W2018291740 modified "2023-09-25" @default.
- W2018291740 title "Cefadroxil in hyperimmunoglobulin E syndrome" @default.
- W2018291740 cites W103320289 @default.
- W2018291740 cites W2036778372 @default.
- W2018291740 cites W2081417550 @default.
- W2018291740 cites W2461789410 @default.
- W2018291740 doi "https://doi.org/10.1136/adc.83.2.185" @default.
- W2018291740 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1718424" @default.
- W2018291740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10950750" @default.
- W2018291740 hasPublicationYear "2000" @default.
- W2018291740 type Work @default.
- W2018291740 sameAs 2018291740 @default.
- W2018291740 citedByCount "1" @default.
- W2018291740 crossrefType "journal-article" @default.
- W2018291740 hasAuthorship W2018291740A5003412641 @default.
- W2018291740 hasAuthorship W2018291740A5004863632 @default.
- W2018291740 hasAuthorship W2018291740A5089928210 @default.
- W2018291740 hasBestOaLocation W20182917401 @default.
- W2018291740 hasConcept C16005928 @default.
- W2018291740 hasConcept C2780131815 @default.
- W2018291740 hasConcept C501593827 @default.
- W2018291740 hasConcept C64778159 @default.
- W2018291740 hasConcept C71924100 @default.
- W2018291740 hasConcept C86803240 @default.
- W2018291740 hasConcept C89423630 @default.
- W2018291740 hasConceptScore W2018291740C16005928 @default.
- W2018291740 hasConceptScore W2018291740C2780131815 @default.
- W2018291740 hasConceptScore W2018291740C501593827 @default.
- W2018291740 hasConceptScore W2018291740C64778159 @default.
- W2018291740 hasConceptScore W2018291740C71924100 @default.
- W2018291740 hasConceptScore W2018291740C86803240 @default.
- W2018291740 hasConceptScore W2018291740C89423630 @default.
- W2018291740 hasIssue "2" @default.
- W2018291740 hasLocation W20182917401 @default.
- W2018291740 hasLocation W20182917402 @default.
- W2018291740 hasLocation W20182917403 @default.
- W2018291740 hasLocation W20182917404 @default.
- W2018291740 hasOpenAccess W2018291740 @default.
- W2018291740 hasPrimaryLocation W20182917401 @default.
- W2018291740 hasRelatedWork W1995515455 @default.
- W2018291740 hasRelatedWork W2080531066 @default.
- W2018291740 hasRelatedWork W2417454872 @default.
- W2018291740 hasRelatedWork W2748952813 @default.
- W2018291740 hasRelatedWork W2899084033 @default.
- W2018291740 hasRelatedWork W3031052312 @default.
- W2018291740 hasRelatedWork W3032375762 @default.
- W2018291740 hasRelatedWork W3093638236 @default.
- W2018291740 hasRelatedWork W4252230854 @default.
- W2018291740 hasRelatedWork W4297184974 @default.
- W2018291740 hasVolume "83" @default.
- W2018291740 isParatext "false" @default.
- W2018291740 isRetracted "false" @default.
- W2018291740 magId "2018291740" @default.
- W2018291740 workType "article" @default.